Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Zagury

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|November 15, 1986
Evidence for HTLV-III/LAV expression by primary cultures of T8 cellsM Fouchard, B Reveil, K Mbayo, et al.
Cancer Research|September 1, 1985
Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell lineD Zagury, M Fouchard, R Cheynier, et al.
Science (New York, N.Y.)|February 21, 1986
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDSD Zagury, J Bernard, R Leonard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC)A Lachgar, G Jaureguiberry, H Le Buenac, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Restoration of immune response by a cationic amphiphilic drug (AY 9944) in vitro: a new approach To chemotherapy against human immunodeficiency virus type 1A Achour, J C Landureau, R Salerno-Goncalves, et al.
Cell Death and Differentiation|January 1, 1995
Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis?J F Zagury, V Chams, A Lachgar, et al.
Journal of Virology|January 9, 1999
Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteinsA Lachgar, N Sojic, S Arbault, et al.
Annals of the Rheumatic Diseases|November 29, 2007
Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalphaL Delavallée, H Le Buanec, N Bessis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor mediumJ C Mazière, J C Landureau, P Giral, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|November 15, 1986
Evidence for HTLV-III/LAV expression by primary cultures of T8 cellsM Fouchard, B Reveil, K Mbayo, et al.
Cancer Research|September 1, 1985
Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell lineD Zagury, M Fouchard, R Cheynier, et al.
Science (New York, N.Y.)|February 21, 1986
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDSD Zagury, J Bernard, R Leonard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC)A Lachgar, G Jaureguiberry, H Le Buenac, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Restoration of immune response by a cationic amphiphilic drug (AY 9944) in vitro: a new approach To chemotherapy against human immunodeficiency virus type 1A Achour, J C Landureau, R Salerno-Goncalves, et al.
Cell Death and Differentiation|January 1, 1995
Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis?J F Zagury, V Chams, A Lachgar, et al.
Journal of Virology|January 9, 1999
Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteinsA Lachgar, N Sojic, S Arbault, et al.
Annals of the Rheumatic Diseases|November 29, 2007
Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalphaL Delavallée, H Le Buanec, N Bessis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor mediumJ C Mazière, J C Landureau, P Giral, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Pageof 12